(282 days)
Not Found
No
The device description and performance studies focus on mechanical and physical properties of a tracheostomy tube, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No
The device is used to provide an artificial airway, which is a supportive function rather than directly treating a disease. Its purpose is to facilitate breathing and airway management, not to cure or mitigate a condition.
No
Explanation: The device creates an artificial airway for treatment and airway management. It does not perform any diagnostic function.
No
The device description clearly outlines physical components such as an Outer Cannula, Cuff, Inflation System, Luer Valve, Pilot Balloon, Neck Plate, and Inner Cannula, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is used to provide an artificial airway to assist in the treatment of respiratory diseases and airway management. This is a therapeutic and supportive function, not a diagnostic one.
- Device Description: The description details the physical components of a tracheostomy tube, which is a medical device used for airway management. It does not describe any components or functions related to analyzing biological samples (like blood, urine, or tissue) to diagnose a condition.
- Lack of Diagnostic Function: There is no mention of the device being used to detect, measure, or analyze any substance or characteristic within the body for diagnostic purposes.
- Anatomical Site: The device is placed in the neck and trachea, which is consistent with an airway management device, not a diagnostic device that typically interacts with biological samples.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device's function is to provide an airway, which is a direct intervention for patient support and treatment.
N/A
Intended Use / Indications for Use
The device is used to provide an artificial airway in order to assist in the treatment of a variety of respiratory diseases and airway management. The device is intubated into the patient's neck and trachea through an opening that is created with dilators that are supplied in a separate Percutaneous Dilational Tracheotomy Kit. The intubation is performed by first inserting an Introducer, also supplied with the Kit, into the Trach Tube and second by passing the Introducer over a Guide Wire and finally through the dilated opening. The device is secured in place with sutures or by using a strap around the patient's neck which is attached to an integral neck plate, thereby providing for a secure artificial airway for ventilation or anesthesia equipment. The Cuff is intended to manage Tidal Volume leakage during Positive Pressure Ventilation and to assist in managing aspiration of food, fluids and secretions into the patient's lung.
This device is used to provide annartificial airway inforder torassist in commen the treatment of a variety of respiratory diseases and airway management for adult patients.
The device is to be used by the order of a nhysician.
The device is primarily intended for use in conjunction with Percutaneous Dilational (or Dilatational) Tracheotomy and is inserted into the natient using the Introducer provided with the Percutaneous Dilational Kit.
The device is intended to be used as the initial artificial airway immediately post tracheotomy.
There is no "new" intended theraneutic use of this device to existing devices marketed.
Product codes (comma separated list FDA assigned to the subject device)
73 JOH
Device Description
The device includes an Outer Cannula with a Cuff. The Cuff is deflated or inflated via an Inflation System comprised of tubing communicating between the Cuff and a Luer Valve to which a syringe can be attached. A Pilot Balloon is adjacent to the Luer Valve to indicate the inflation status of the Cuff. A Neck Plate is attached to the Outer Cannula. An Inner Cannula is included with an integral 15mm male conical connector. The Inner and Outer Cannula are attached together by a snap-lock mechanism. The Outer Cannula distal end is designed to have smooth transitions in outer diameter in order to minimize the amount of resistance that would occur with abrupt transitions.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's neck and trachea
Indicated Patient Age Range
adult patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests:
Physical integrity of the Cuff-to-Cannula bond strength of the new PERC device will be demonstrated to be equivalent to the predicate DCT device.
Insertion force of the new PERC device will be less than that of the predicate DCT device.
This data will be available from the manufacturer upon request.
Clinical Tests:
It is not required to conduct clinical tests on the new PERC product due to its similarity to the predicate DCT product and other competitor's predicate products. Moreover, we estimate that approximately 4000 DCTs are currently used in this application annually. The acceptance of the predicate DCT in this application eliminates the need to validate the acceptance of the new PERC product in this application because of the minor nature of the improvements.
Conclusion:
The similarity to the predicate products in conjunction together with the extensive usage of the predicate product in Percutaneous Dilational Tracheotomy applications, demonstrate that the new PERC product is safe and effective and will perform equal to or better than currently marketed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5800 Tracheostomy tube and tube cuff.
(a)
Identification. A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.(b)
Classification. Class II.
0
SECTION 9; 510(k) SUMMARY OF SAFETY AND EFFICACY:
(summary pg 1 of
- (1) Company Name Mallinckrodt Medical, Inc.
June 26, 1957
Address. Telephone and Contact
| Corporate Headquarters | Manufacturing and Distribution Location |
|---|---|
| Mallinckrodt Medical, Inc. | |
| P.O. Box 5840 | |
| St. Louis, MO 63134 |
Mike Schoeck
(314) 895-2318 | Mallinckrodt Medical, Inc.
18691 Jamboree Road
Irvine, CA 92712
Tony Wondka
(714) 622-5797 |
August 1996 Date of submission
- Shiley Percutaneous Dual Cannula Tracheostomy Tube with Low (2) Trade Names Pressure / Lower Profile Cuff and Disposable Inner Cannula
Common or Usual Name Tracheostomy Tube, Adult, with Cuff
Class II Classification
- Substantially Equivalent Devices Registration numbers: (3)
- (4) Intended Use; The device is used to provide an artificial airway in order to assist in the treatment of a variety of respiratory diseases and airway management. The device is intubated into the patient's neck and trachea through an opening that is created with dilators that are supplied in a separate Percutaneous Dilational Tracheotomy Kit. The intubation is performed by first inserting an Introducer, also supplied with the Kit, into the Trach Tube and second by passing the Introducer over a Guide Wire and finally through the dilated opening. The device is secured in place with sutures or by using a strap around the patient's neck which is attached to an integral neck plate, thereby providing for a secure artificial airway for ventilation or anesthesia equipment. The Cuff is intended to manage Tidal Volume leakage during Positive Pressure Ventilation and to assist in managing aspiration of food, fluids and secretions into the patient's lung.
- (5) Description and Physical Characteristics: The device includes an Outer Cannula with a Cuff. The Cuff is deflated or inflated via an Inflation System comprised of tubing communicating between the Cuff and a Luer Valve to which a syringe can be attached. A Pilot Balloon is adjacent to the Luer Valve to indicate the inflation status of the Cuff. A Neck Plate is attached to the Outer Cannula. An Inner Cannula is included with an integral 15mm male conical connector. The Inner and Outer Cannula are attached together by a snap-lock mechanism. The Outer Cannula distal end is designed to have smooth transitions in outer diameter in order to minimize the amount of resistance that would occur with abrupt transitions.
- (6) Materials: The device consists of an Outer Cannula, Cuff, Inflation Line, Pilot Balloon, Luer Valve and Inner Cannula all constructed with biocompatible polyvinyl chloride, an obturator and 15mm male connector both constructed with biocompatible polypropylene, and a neck plate constructed with biocompatible polycarbonate.
1
(7) Differences from Predicate Devices referenced herein:
The device is not different in safety or efficacy from the predicate device(s). The design 1110 wones between the new PERC device and the Shiley 'DCT' predicate device are related to a relatively smooth tip for the PERC compared to the DCT.
Similarities to DCT and SCT devices:
- Dual Cannula System (same as DCT) 1)
-
- Inner Cannula in its entirety (same as DCT)
- Outer Cannula length (same as DCT) કો
- Outer Cannula ID and OD (same as DCT) 4)
- Cuff and Inflation System components (same as DCT) 5)
- Cuff attachment to Outer Cannula (same as DCT and SCT) 6)
- Inflation Line attachment to Outer Cannula (same as DCT) 7)
- Intended Use of device (same as DCT) 8)
- Sterilization Method (same as DCT and SCT) 9)
Differences from DCT device:
Physical Characteristics:
-
The Outer Cannula includes a distal tip section that has smooth gradual transitions in 1) diameter. This is accomplished by eliminating the lip caused by the rim of the distal cuff bond. In addition, the proximal Cuff bond is inverted to reduce the effective diameter of this section of the device. These characteristics are intended reduce the amount of force necessary to insert the device into the patient.
Labeling and User Instructions: -
The device instruction sheet will include references to Cuff Resting Diameter, 1) Cannula Angle, and Proximal and Distal Extensions as suggested in the ISO and CEN standards.
-
- A statement will be added to the packaging indicating that the new device is compatible with Introducers provided with Percutaneous Dilational Tracheotomy Kits.
-
- A Caution statement indicating that physicians using this device with a Percutaneous Dilational Tracheotomy Procedure should be properly instructed on the procedure prior to use.
-
- A Caution statement indicating that prior to intubation of this device, that the preceding Percutaneous Dilational Tracheotomy Procedure be performed with visual confirmation of needle and/or guide catheter placement from inside the trachea with a bronchoscope or similar manner.
-
A statement will be added that states sterile technique should be used when 5) inserting the device into the patient since the intubation will be performed in conjunction with a Percutaneous Dilational Tracheotomy Procedure.
-
- A statement will be added to describe a method of deflating the device prior to removal from the patient to taper the cuff in the direction of removal,
2
Test Summary: (8)
- Non-Clinical Tests: 1)
Physical integrity of the Cuff-to-Cannula bond strength of the new PERC device will be demonstrated to be equivalent to the predicate DCT device.
Insertion force of the new PERC device will be less than that of the predicate DCT device.
This data will be available from the manufacturer upon request.
-
- Clinical Tests:
It is not required to conduct clinical tests on the new PERC product due to its similarity to the predicate DCT product and other competitor's predicate products. Moreover, we estimate that approximately 4000 DCTs are currently used in this application annually. The acceptance of the predicate DCT in this application eliminates the need to validate the acceptance of the new PERC product in this application because of the minor nature of the improvements.
- Clinical Tests:
-
Conclusion: 3)
The similarity to the predicate products in conjunction together with the extensive usage of the predicate product in Percutaneous Dilational Tracheotomy applications, demonstrate that the new PERC product is safe and effective and will perform equal to or better than currently marketed predicate devices.
3
Image /page/3/Picture/1 description: The image contains the text "Public Health Service". The text is in a bold, sans-serif font. The words are arranged vertically, with "Public" on the top line, "Health" on the second line, and "Service" on the third line. The text is black against a white background.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 26 1997
Mr. James E. Keller Mallinckrodt Medical, Inc. 675 McDonnell Boulevard P.O. Box 5840 St. Louis, Missouri 63134
K963732 Re : Percutaneous Dual Cannula Tracheostomy Tube with Low Pressure/Low Profile Cuff and Disposable Inner Cannula Regulatory Class: II (two) 73 JOH Product Code: Dated: May 8, 1997 Received: May 12, 1997
Dear Mr. Keller:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 A substantially equivalent determination assumes compliance to 895. with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page 2 - Mr. James E. Keller
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahon
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known):
Percutaneous Dual Cannula Tracheostomy Tube Device Name:
Indications For Use:
- This device is used to provide annartificial airway inforder torassist in commen 1. the treatment of a variety of respiratory diseases and airway management for adult patients.
- The device is to be used by the order of a nhysician. 2.
- The device is primarily intended for use in conjunction with Percutaneous 3. Dilational (or Dilatational) Tracheotomy and is inserted into the natient using the Introducer provided with the Percutaneous Dilational Kit.
-
- The device is intended to be used as the initial artificial airway immediately post tracheotomy.
-
- There is no "new" intended theraneutic use of this device to existing devices marketed.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | ||
|---|---|---|
| M | ||
| (Division Sign-Off) | ||
| Division of Cardiovascular, | ||
| and Neurological Devices | ||
| 510(k) Number | K96 3732 | |
| Prescription Use | ||
| (Per 21 CFR 801.109) | OR | Over-The-Counter Use |
(Optional Format 1-2-96)